Lili Zhang

Lili Zhang is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Senior Vice President and Head of Preclinical Development at APRINOIA Therapeutics since February 2022. Lili also holds the position of Principal at LZ Bioscience Consulting, LLC since January 2020. Prior roles include Senior Director of Discovery Biology at Dewpoint Therapeutics, Senior Director of Neurodegeneration and Director of Biology for Alzheimer's Disease at Aquinnah Pharmaceuticals, and Senior Investigator I at the Novartis Institute of Biomedical Research. Earlier in the career, Lili was Director of Neuroscience/Biology Lead for Alzheimer's Disease at Merck Research Laboratories and Senior Principal Scientist at Schering-Plough Research Institute. The academic background includes a Ph.D. from the University of Illinois Urbana-Champaign and a Bachelor's degree from Peking University.